Analysis of possible drug-drug interactions between ritonavir and other antiretrovirals in a section of the private health care sector in South Africa

BACKGROUND: The introduction of human immunodeficiency virus (HIV) protease inhibitors (PIs) has led to a dramatic decline in the morbidity and mortality associated with HIV infection. However, the concomitant use of PIs and other antiretrovirals (ARVs) can be complicated by drug-drug interactions (...

Descripción completa

Detalles Bibliográficos
Autores principales: Katende-Kyenda, Norah L., Lubbe, Martie S., Serfontein, Jan H.P., Truter, Ilse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AOSIS OpenJournals 2009
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565919/
http://dx.doi.org/10.4102/phcfm.v1i1.21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565919/
http://dx.doi.org/10.4102/phcfm.v1i1.21

Ejemplares similares